550 related articles for article (PubMed ID: 29184552)
1. Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.
de Andrade Mello P; Coutinho-Silva R; Savio LEB
Front Immunol; 2017; 8():1526. PubMed ID: 29184552
[TBL] [Abstract][Full Text] [Related]
2. The yin and yang functions of extracellular ATP and adenosine in tumor immunity.
Feng LL; Cai YQ; Zhu MC; Xing LJ; Wang X
Cancer Cell Int; 2020; 20():110. PubMed ID: 32280302
[TBL] [Abstract][Full Text] [Related]
3. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
Bao X; Xie L
J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
[TBL] [Abstract][Full Text] [Related]
4. The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy.
Kang C; Liu L; Wu C; Li L; Jia X; Xie W; Chen S; Wu X; Zheng H; Liu J; Li R; Zeng B
Front Immunol; 2023; 14():1111369. PubMed ID: 36911717
[TBL] [Abstract][Full Text] [Related]
5. The P2X7 Receptor in Tumor Immunity.
Grassi F; De Ponte Conti B
Front Cell Dev Biol; 2021; 9():694831. PubMed ID: 34239877
[TBL] [Abstract][Full Text] [Related]
6. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
Silva-Vilches C; Ring S; Mahnke K
Front Immunol; 2018; 9():2581. PubMed ID: 30473700
[TBL] [Abstract][Full Text] [Related]
7. Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.
Vaupel P; Multhoff G
Strahlenther Onkol; 2016 May; 192(5):279-87. PubMed ID: 26961686
[TBL] [Abstract][Full Text] [Related]
8. Extracellular purines, purinergic receptors and tumor growth.
Di Virgilio F; Adinolfi E
Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
[TBL] [Abstract][Full Text] [Related]
9. Adenosine signaling: Next checkpoint for gastric cancer immunotherapy?
Shi L; Yang L; Wu Z; Xu W; Song J; Guan W
Int Immunopharmacol; 2018 Oct; 63():58-65. PubMed ID: 30075429
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancer and Purinergic Signalling: An Overview.
Roliano GG; Azambuja JH; Brunetto VT; Butterfield HE; Kalil AN; Braganhol E
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230810
[TBL] [Abstract][Full Text] [Related]
11. Purinergic Signaling Within the Tumor Microenvironment.
Draganov D; Lee PP
Adv Exp Med Biol; 2021; 1270():73-87. PubMed ID: 33123994
[TBL] [Abstract][Full Text] [Related]
12. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.
Bours MJ; Swennen EL; Di Virgilio F; Cronstein BN; Dagnelie PC
Pharmacol Ther; 2006 Nov; 112(2):358-404. PubMed ID: 16784779
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signaling in scarring.
Ferrari D; Gambari R; Idzko M; Müller T; Albanesi C; Pastore S; La Manna G; Robson SC; Cronstein B
FASEB J; 2016 Jan; 30(1):3-12. PubMed ID: 26333425
[TBL] [Abstract][Full Text] [Related]
14. Extracellular ATP signaling and clinical relevance.
Dou L; Chen YF; Cowan PJ; Chen XP
Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
[TBL] [Abstract][Full Text] [Related]
15. Targeting Adenosine Receptor Signaling in Cancer Immunotherapy.
Sek K; Mølck C; Stewart GD; Kats L; Darcy PK; Beavis PA
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513816
[TBL] [Abstract][Full Text] [Related]
16. The CD73/Ado System-A New Player in RT Induced Adverse Late Effects.
de Leve S; Wirsdörfer F; Jendrossek V
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623231
[TBL] [Abstract][Full Text] [Related]
17. Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes.
Debom GN; Rubenich DS; Braganhol E
Front Neurosci; 2021; 15():648476. PubMed ID: 35069091
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models
Demeules M; Scarpitta A; Hardet R; Gondé H; Abad C; Blandin M; Menzel S; Duan Y; Rissiek B; Magnus T; Mann AM; Koch-Nolte F; Adriouch S
Front Immunol; 2022; 13():1012534. PubMed ID: 36341324
[TBL] [Abstract][Full Text] [Related]
19. [Progress on role of extracellular ATP and its metabolite adenosine in immunoregulation: Review].
Wang C; Yin Q; Su Z; Xia L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1134-1140. PubMed ID: 33325366
[TBL] [Abstract][Full Text] [Related]
20. CD39/CD73/A2AR pathway and cancer immunotherapy.
Xia C; Yin S; To KKW; Fu L
Mol Cancer; 2023 Mar; 22(1):44. PubMed ID: 36859386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
